Antiphospholipid syndrome in lupus retinopathy

Ng, Hong Kee and Chong, Mei Fong and Yaakub, Azhany and Embong, Zunaina (2014) Antiphospholipid syndrome in lupus retinopathy. Clinical Ophthalmology, 2014 (8). pp. 2359-2363. ISSN 1177-5467

Download (1MB) | Preview


Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease that can affect any part of the human body including the eyes. Common blinding ocular manifestations include central retinal artery occlusion (CRAO), central retinal vein occlusion (CRVO), severe vaso-occlusive retinopathy, and optic nerve involvement. Antiphospholipid syndrome (APS) in lupus is usually associated with large vessel occlusions and needs prompt treatment with anticoagulant. We are reporting two cases of APS in SLE patients that presented with CRVO (case 1) and vaso-occlusive lupus retinopathy (case 2). Both cases were positive for antiphospholipid antibody (APA) and were treated with immunosuppression, anticoagulant, and laser treatment. Thus, screening for APA is vital in SLE patients with lupus retinopathy, as prompt treatment with anticoagulants is important to prevent further vascular thrombosis, which worsens the visual prognosis.

Item Type: Article
Subjects: R Medicine > RE Ophthalmology
Divisions: Kampus Kesihatan (Health Campus) > Pusat Pengajian Sains Perubatan (School of Medical Sciences) > Article
Depositing User: Mr Noorazilan Noordin
Date Deposited: 11 Jan 2018 03:59
Last Modified: 11 Jan 2018 03:59

Actions (login required)

View Item View Item